Report Detail

Other Global (United States, European Union and China) Internal Neuromodulation Market Research Report 2019-2025

  • RnM3672730
  • |
  • 16 August, 2019
  • |
  • Global
  • |
  • 118 Pages
  • |
  • QYResearch
  • |
  • Other

Neuromodulation is used to regulate functions of nervous system, such as therapeutic alteration, inhibition, stimulation, modification, and others. There are two types of neuromodulation external neuromodulation and internal neuromodulation. Internal neuromodulation block or repair neuron signals of pain from reaching the brain using electrical impulses. These devices reduce highest levels of pain for various chronic or refractory diseases. Its clinical significance in pain reduction and therapeutics has lead a wide acceptance in the North American region.
The driving factors of the internal neuromodulation market are rising prevalence of neurological disorders, increase in the aging population, strong product pipeline, expanded target applications and new indications, and investments and funds. Moreover, technological advancements present opportunities for growth of the market.
In 2019, the market size of Internal Neuromodulation is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Internal Neuromodulation.

This report studies the global market size of Internal Neuromodulation, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Internal Neuromodulation production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Medtronic PLC
St. Jude Medical
Boston Scientific Corp.
Cerbomed GMBH
Cyberonics
Biocontrol Medical
Depuy Synthes Companies
Enteromedics
Synapse Biomedical
Uroplasty
Greatbatch

Market Segment by Product Type
Spinal Cord Stimulator
Deep Brain Stimulator
Sacral Nerve Stimulator
Vagus Nerve Stimulator
Gastric Neuro Stimulator

Market Segment by Application
Parkinsons Disease
Chronic Pain
Others

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Internal Neuromodulation status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Internal Neuromodulation manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Internal Neuromodulation are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025


Table of Contents

    1 Report Overview

    • 1.1 Research Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Internal Neuromodulation Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Spinal Cord Stimulator
      • 1.3.3 Deep Brain Stimulator
      • 1.3.4 Sacral Nerve Stimulator
      • 1.3.5 Vagus Nerve Stimulator
      • 1.3.6 Gastric Neuro Stimulator
    • 1.4 Market Segment by Application
      • 1.4.1 Global Internal Neuromodulation Market Share by Application (2019-2025)
      • 1.4.2 Parkinsons Disease
      • 1.4.3 Chronic Pain
      • 1.4.4 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Production and Capacity Analysis
      • 2.1.1 Global Internal Neuromodulation Production Value 2014-2025
      • 2.1.2 Global Internal Neuromodulation Production 2014-2025
      • 2.1.3 Global Internal Neuromodulation Capacity 2014-2025
      • 2.1.4 Global Internal Neuromodulation Marketing Pricing and Trends
    • 2.2 Key Producers Growth Rate (CAGR) 2019-2025
      • 2.2.1 Global Internal Neuromodulation Market Size CAGR of Key Regions
      • 2.2.2 Global Internal Neuromodulation Market Share of Key Regions
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Capacity and Production by Manufacturers
      • 3.1.1 Global Internal Neuromodulation Capacity by Manufacturers
      • 3.1.2 Global Internal Neuromodulation Production by Manufacturers
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Internal Neuromodulation Revenue by Manufacturers (2014-2019)
      • 3.2.2 Internal Neuromodulation Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Internal Neuromodulation Market Concentration Ratio (CR5 and HHI)
    • 3.3 Internal Neuromodulation Price by Manufacturers
    • 3.4 Key Manufacturers Internal Neuromodulation Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Internal Neuromodulation Market
    • 3.6 Key Manufacturers Internal Neuromodulation Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Production and Production Value for Each Type
      • 4.1.1 Spinal Cord Stimulator Production and Production Value (2014-2019)
      • 4.1.2 Deep Brain Stimulator Production and Production Value (2014-2019)
      • 4.1.3 Sacral Nerve Stimulator Production and Production Value (2014-2019)
      • 4.1.4 Vagus Nerve Stimulator Production and Production Value (2014-2019)
      • 4.1.5 Gastric Neuro Stimulator Production and Production Value (2014-2019)
    • 4.2 Global Internal Neuromodulation Production Market Share by Type
    • 4.3 Global Internal Neuromodulation Production Value Market Share by Type
    • 4.4 Internal Neuromodulation Ex-factory Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Internal Neuromodulation Consumption by Application

    6 Production by Regions

    • 6.1 Global Internal Neuromodulation Production (History Data) by Regions 2014-2019
    • 6.2 Global Internal Neuromodulation Production Value (History Data) by Regions
    • 6.3 United States
      • 6.3.1 United States Internal Neuromodulation Production Growth Rate 2014-2019
      • 6.3.2 United States Internal Neuromodulation Production Value Growth Rate 2014-2019
      • 6.3.3 Key Players in United States
      • 6.3.4 United States Internal Neuromodulation Import & Export
    • 6.4 European Union
      • 6.4.1 European Union Internal Neuromodulation Production Growth Rate 2014-2019
      • 6.4.2 European Union Internal Neuromodulation Production Value Growth Rate 2014-2019
      • 6.4.3 Key Players in European Union
      • 6.4.4 European Union Internal Neuromodulation Import & Export
    • 6.5 China
      • 6.5.1 China Internal Neuromodulation Production Growth Rate 2014-2019
      • 6.5.2 China Internal Neuromodulation Production Value Growth Rate 2014-2019
      • 6.5.3 Key Players in China
      • 6.5.4 China Internal Neuromodulation Import & Export
    • 6.6 Rest of World
      • 6.6.1 Japan
      • 6.6.2 Korea
      • 6.6.3 India
      • 6.6.4 Southeast Asia

    7 Internal Neuromodulation Consumption by Regions

    • 7.1 Global Internal Neuromodulation Consumption (History Data) by Regions
    • 7.2 United States
      • 7.2.1 United States Internal Neuromodulation Consumption by Type
      • 7.2.2 United States Internal Neuromodulation Consumption by Application
    • 7.3 European Union
      • 7.3.1 European Union Internal Neuromodulation Consumption by Type
      • 7.3.2 European Union Internal Neuromodulation Consumption by Application
    • 7.4 China
      • 7.4.1 China Internal Neuromodulation Consumption by Type
      • 7.4.2 China Internal Neuromodulation Consumption by Application
    • 7.5 Rest of World
      • 7.5.1 Rest of World Internal Neuromodulation Consumption by Type
      • 7.5.2 Rest of World Internal Neuromodulation Consumption by Application
      • 7.5.1 Japan
      • 7.5.2 Korea
      • 7.5.3 India
      • 7.5.4 Southeast Asia

    8 Company Profiles

    • 8.1 Medtronic PLC
      • 8.1.1 Medtronic PLC Company Details
      • 8.1.2 Company Description and Business Overview
      • 8.1.3 Production and Revenue of Internal Neuromodulation
      • 8.1.4 Internal Neuromodulation Product Introduction
      • 8.1.5 Medtronic PLC Recent Development
    • 8.2 St. Jude Medical
      • 8.2.1 St. Jude Medical Company Details
      • 8.2.2 Company Description and Business Overview
      • 8.2.3 Production and Revenue of Internal Neuromodulation
      • 8.2.4 Internal Neuromodulation Product Introduction
      • 8.2.5 St. Jude Medical Recent Development
    • 8.3 Boston Scientific Corp.
      • 8.3.1 Boston Scientific Corp. Company Details
      • 8.3.2 Company Description and Business Overview
      • 8.3.3 Production and Revenue of Internal Neuromodulation
      • 8.3.4 Internal Neuromodulation Product Introduction
      • 8.3.5 Boston Scientific Corp. Recent Development
    • 8.4 Cerbomed GMBH
      • 8.4.1 Cerbomed GMBH Company Details
      • 8.4.2 Company Description and Business Overview
      • 8.4.3 Production and Revenue of Internal Neuromodulation
      • 8.4.4 Internal Neuromodulation Product Introduction
      • 8.4.5 Cerbomed GMBH Recent Development
    • 8.5 Cyberonics
      • 8.5.1 Cyberonics Company Details
      • 8.5.2 Company Description and Business Overview
      • 8.5.3 Production and Revenue of Internal Neuromodulation
      • 8.5.4 Internal Neuromodulation Product Introduction
      • 8.5.5 Cyberonics Recent Development
    • 8.6 Biocontrol Medical
      • 8.6.1 Biocontrol Medical Company Details
      • 8.6.2 Company Description and Business Overview
      • 8.6.3 Production and Revenue of Internal Neuromodulation
      • 8.6.4 Internal Neuromodulation Product Introduction
      • 8.6.5 Biocontrol Medical Recent Development
    • 8.7 Depuy Synthes Companies
      • 8.7.1 Depuy Synthes Companies Company Details
      • 8.7.2 Company Description and Business Overview
      • 8.7.3 Production and Revenue of Internal Neuromodulation
      • 8.7.4 Internal Neuromodulation Product Introduction
      • 8.7.5 Depuy Synthes Companies Recent Development
    • 8.8 Enteromedics
      • 8.8.1 Enteromedics Company Details
      • 8.8.2 Company Description and Business Overview
      • 8.8.3 Production and Revenue of Internal Neuromodulation
      • 8.8.4 Internal Neuromodulation Product Introduction
      • 8.8.5 Enteromedics Recent Development
    • 8.9 Synapse Biomedical
      • 8.9.1 Synapse Biomedical Company Details
      • 8.9.2 Company Description and Business Overview
      • 8.9.3 Production and Revenue of Internal Neuromodulation
      • 8.9.4 Internal Neuromodulation Product Introduction
      • 8.9.5 Synapse Biomedical Recent Development
    • 8.10 Uroplasty
      • 8.10.1 Uroplasty Company Details
      • 8.10.2 Company Description and Business Overview
      • 8.10.3 Production and Revenue of Internal Neuromodulation
      • 8.10.4 Internal Neuromodulation Product Introduction
      • 8.10.5 Uroplasty Recent Development
    • 8.11 Greatbatch

    9 Market Forecast

    • 9.1 Global Market Size Forecast
      • 9.1.1 Global Internal Neuromodulation Capacity, Production Forecast 2019-2025
      • 9.1.2 Global Internal Neuromodulation Production Value Forecast 2019-2025
    • 9.2 Market Forecast by Regions
      • 9.2.1 Global Internal Neuromodulation Production and Value Forecast by Regions 2019-2025
      • 9.2.2 Global Internal Neuromodulation Consumption Forecast by Regions 2019-2025
    • 9.3 United States
      • 9.3.1 Production and Value Forecast in United States
      • 9.3.2 Consumption Forecast in United States
    • 9.4 European Union
      • 9.4.1 Production and Value Forecast in European Union
      • 9.4.2 Consumption Forecast in European Union
    • 9.5 China
      • 9.5.1 Production and Value Forecast in China
      • 9.5.2 Consumption Forecast in China
    • 9.6 Rest of World
      • 9.6.1 Japan
      • 9.6.2 Korea
      • 9.6.3 India
      • 9.6.4 Southeast Asia
    • 9.7 Forecast by Type
      • 9.7.1 Global Internal Neuromodulation Production Forecast by Type
      • 9.7.2 Global Internal Neuromodulation Production Value Forecast by Type
    • 9.8 Consumption Forecast by Application

    10 Value Chain and Sales Channels Analysis

    • 10.1 Value Chain Analysis
    • 10.2 Sales Channels Analysis
      • 10.2.1 Internal Neuromodulation Sales Channels
      • 10.2.2 Internal Neuromodulation Distributors
    • 10.3 Internal Neuromodulation Customers

    11 Opportunities & Challenges, Threat and Affecting Factors

    • 11.1 Market Opportunities
    • 11.2 Market Challenges
    • 11.3 Porter's Five Forces Analysis

    12 Key Findings

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
          • 13.1.1.1 Research Programs/Design
          • 13.1.1.2 Market Size Estimation
          • 13.1.1.3 Market Breakdown and Data Triangulation
        • 13.1.2 Data Source
          • 13.1.2.1 Secondary Sources
          • 13.1.2.2 Primary Sources
      • 13.2 Author Details

      Summary:
      Get latest Market Research Reports on Internal Neuromodulation. Industry analysis & Market Report on Internal Neuromodulation is a syndicated market report, published as Global (United States, European Union and China) Internal Neuromodulation Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Internal Neuromodulation market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,280.00
      $4,920.00
      $6,560.00
      2,584.64
      3,876.96
      5,169.28
      3,017.60
      4,526.40
      6,035.20
      510,991.20
      766,486.80
      1,021,982.40
      273,420.80
      410,131.20
      546,841.60
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report